Drug Shortage Report for APTIOM
| Report ID | 238559 |
| Drug Identification Number | 02426897 |
| Brand name | APTIOM |
| Common or Proper name | eslicarbazepine acetate tablets |
| Company Name | SUMITOMO PHARMA CANADA, INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ESLICARBAZEPINE ACETATE |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 tablets per bottle |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-10-31 |
| Actual start date | |
| Estimated end date | 2024-11-30 |
| Actual end date | 2024-10-28 |
| Shortage status | Avoided shortage |
| Updated date | 2024-10-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7025 LANGER DRIVE MISSISSAUGA, ONTARIO CANADA L5N 0E8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-10-28 | French | Compare |
| v4 | 2024-10-28 | English | Compare |
| v3 | 2024-09-26 | French | Compare |
| v2 | 2024-09-26 | English | Compare |
| v1 | 2024-09-26 | English | Compare |
Showing 1 to 5 of 5